1. Home
  2. KRYS vs DOOO Comparison

KRYS vs DOOO Comparison

Compare KRYS & DOOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • DOOO
  • Stock Information
  • Founded
  • KRYS 2015
  • DOOO 1937
  • Country
  • KRYS United States
  • DOOO Canada
  • Employees
  • KRYS N/A
  • DOOO N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • DOOO
  • Sector
  • KRYS Health Care
  • DOOO
  • Exchange
  • KRYS Nasdaq
  • DOOO Nasdaq
  • Market Cap
  • KRYS 4.3B
  • DOOO 4.8B
  • IPO Year
  • KRYS 2017
  • DOOO N/A
  • Fundamental
  • Price
  • KRYS $144.86
  • DOOO $64.97
  • Analyst Decision
  • KRYS Strong Buy
  • DOOO Buy
  • Analyst Count
  • KRYS 10
  • DOOO 5
  • Target Price
  • KRYS $204.90
  • DOOO $62.75
  • AVG Volume (30 Days)
  • KRYS 268.2K
  • DOOO 372.4K
  • Earning Date
  • KRYS 11-03-2025
  • DOOO 08-29-2025
  • Dividend Yield
  • KRYS N/A
  • DOOO 0.94%
  • EPS Growth
  • KRYS 36.22
  • DOOO N/A
  • EPS
  • KRYS 4.91
  • DOOO N/A
  • Revenue
  • KRYS $359,205,000.00
  • DOOO $5,602,586,799.00
  • Revenue This Year
  • KRYS $34.33
  • DOOO $1.45
  • Revenue Next Year
  • KRYS $47.84
  • DOOO $4.94
  • P/E Ratio
  • KRYS $29.46
  • DOOO N/A
  • Revenue Growth
  • KRYS 116.08
  • DOOO N/A
  • 52 Week Low
  • KRYS $122.80
  • DOOO $31.78
  • 52 Week High
  • KRYS $207.84
  • DOOO $68.42
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 48.61
  • DOOO 63.42
  • Support Level
  • KRYS $136.73
  • DOOO $63.61
  • Resistance Level
  • KRYS $152.96
  • DOOO $68.42
  • Average True Range (ATR)
  • KRYS 4.68
  • DOOO 1.91
  • MACD
  • KRYS -0.69
  • DOOO 0.05
  • Stochastic Oscillator
  • KRYS 50.09
  • DOOO 72.04

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About DOOO BRP Inc. (Recreational Products) Common Subordinate Voting Shares

BRP designs, develops, manufactures, distributes, and markets snowmobiles, all-terrain vehicles, and personal watercraft under the Ski-Doo, Sea-Doo, Can-Am, and Lynx brand names. It also builds engines under the Rotax brand (after shuttering the Evinrude outboard engine business in 2020) and offers clothing, parts, and accessories that cater to its core consumers. In 2018, BRP created a marine group, which has largely been divested (Manitou pontoon boats sale is set to close in the third quarter). At the end of fiscal 2025, the company sold its products through a network of more than 2,400 independent dealers and 140 distributors in around 130 countries.

Share on Social Networks: